SCHEMBL1039748

SCHEMBL1039748

Cc1ccc(O[Si](Oc2ccc(C)cc2)(Oc2ccc(C)cc2)Oc2ccc(C)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.52
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
TEAD4 Q15561 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
LMNA P02545 1/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
RELA Q04206 1/20 0.41
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10323853 0.90 HTT (0.47) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL10323805 0.90 HTT (0.47) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL10574326 0.87 ACHE (0.52) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL7859077 0.85 ACHE (0.44) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL15220292 0.83 ACHE (0.42) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL5393983 0.81 ACHE (0.41) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL2016960 0.80 ACHE (0.50) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL3873409 0.80 ACHE (0.50) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL3871449 0.80 ACHE (0.50) ACHEKMT2AMEN1TDP1CYP3A4
SCHEMBL5604776 0.78 ACHE (0.48) ACHEKMT2AMEN1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250256267-A1 PILLARED STRUCTURES OF LAMELLAR MESOPOROUS CRYSTALLINE MICROPOROUS MATERIAL SAUDI ARABIAN OIL COMPANY (SA) 2025-08-14 US claimed
US-20120184702-A1 PROCESS FOR PRODUCING A COMPOSITE MATERIAL BASF SE (DE) 2012-07-19 US claimed
US-7582712-B1 Alpha-olefins polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2009-09-01 US claimed
US-7528199-B2 Conjugated-diolefin (co)polymer rubber and process for producing the same JSR CORPORATION (JP) 2009-05-05 US claimed
US-7307036-B2 Highly active alpha-olefin polymerization catalyst FORMOSA PLASTICS CORPORATION U.S.A. (US) 2007-12-11 US claimed
US-20060019821-A1 Highly active alpha-olefin polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. 2006-01-26 US claimed
EP-0890580-B1 Diene polymers and copolymers incorporating partial coupling and terminals formed from hydrocarboxysilane compounds BRIDGESTONE CORP (JP) 2003-09-17 EP claimed
US-6228908-B1 Diene polymers and copolymers incorporating partial coupling and terminals formed from hydrocarboxysilane compounds BRIDGESTONE CORPORATION (JP) 2001-05-08 US claimed
US-6008295-A FIRST COUPLING THE LIVING DIENE POLYMER OR COPOLYMER CHAINS OBTAINED BY ANIONIC POLYMERIZATION WITH A TIN HALIDE COUPLING AGENT AND THEN TERMINATING THE REMAINING LIVING POLYMER OR COPOLYMER CHAINS WITH A HYDROCARBOXYSILANE; TIRE TREADS BRIDGESTONE CORPORATION (JP) 1999-12-28 US claimed
EP-0890580-A1 Diene polymers and copolymers incorporating partial coupling and terminals formed from hydrocarboxysilane compounds Bridgestone Corporation (JP) 1999-01-13 EP claimed
EP-0268274-B1 METHOD FOR PRODUCING AN OLEFIN POLYMER MITSUBISHI KASEI CORPORATION (JP) 1992-07-08 EP claimed
US-4970187-A Catalyst for producing an olefin polymer MITSUBISHI KASEI CORPORATION (JP) 1990-11-13 US claimed
US-4902761-A Method for producing an olefin polymer MITSUBISHI KASEI CORPORATION (JP) 1990-02-20 US claimed
US-4883848-A Method for producing an olefin polymer MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1989-11-28 US claimed
EP-0268274-A2 Method for producing an olefin polymer MITSUBISHI KASEI CORPORATION (JP) 1988-05-25 EP claimed
EP-0246599-A1 Method for producing an olefin polymer MITSUBISHI KASEI CORPORATION (JP) 1987-11-25 EP claimed
EP-3916045-B1 HIGH STRENGTH HYDROGENATED POLYMERS, AND RUBBER COMPOSITIONS INCORPORATING SAME BRIDGESTONE CORP (JP) 2026-05-06 EP disclosed
US-20260098105-A1 PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER WITH IMPROVED PROCESSABILITY AND OPTICAL PROPERTIES FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2026-04-09 US disclosed
EP-0145368-A2 Process for producing propylene block copolymers TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) 1985-06-19 EP disclosed
US-4072636-A ORGANO-SILICATE MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098105-A1 PREPOLYMERIZED CATALYST FOR OLEFIN POLYMERIZATION, METHOD OF PRODUCING THIS PREPOLYMERIZED CATALYST AND METHOD OF PRODUCING OLEFIN POLYMER WITH IMPROVED PROCESSABILITY AND OPTICAL PROPERTIES DIS3, DRD4, SRP54 ACHE 4176/4885KMT2A 3899/4885MEN1 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.